Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for PONV prevention in C-section
NCT06681805Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jan 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mirtazapine in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Kafrelsheikh University. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Jan 2023; status: completed.
02
Drugs
mirtazapine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06681805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06681805.